STAT5B and cancer: In support of these findings, Von Manstein et al. [40] previously reported in cancer cells that deactivation of STAT5 by blocking the c-Src kinase enzyme leads to increased activity of STAT3, which then takes the main role as an effector of the JAK/STAT signaling in promoting cell proliferation.